Interés Humano

OMS da su aprobación de emergencia a vacuna china contra covid-19

Vacuna se basa en un adenovirus humano modificado, se administra en una sola dosis y está recomendada para todos los grupos de edad a partir de los 18 años

This photo taken on June 20, 2021 shows a woman receiving the China National Biotec Group (CNBG) Covid-19 coronavirus vaccine in Hangzhou, in China's eastern Zhejiang province. (Photo by STR / AFP) / China OUT
This photo taken on June 20, 2021 shows a woman receiving the China National Biotec Group (CNBG) Covid-19 coronavirus vaccine in Hangzhou, in China's eastern Zhejiang province. (Photo by STR / AFP) / China OUT STR
‌
‌

‌

‌
‌

‌

‌